603998 Hunan Fangsheng Pharmaceutical
- 11.12
- -0.32-2.80%
Hunan Fangsheng Pharmaceutical News
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-040)
Fangsheng Pharmaceutical: Investor Relations Activity Record Form (2024-038, 39)
Fangsheng Pharmaceutical\'s announcement on the holding of the results briefing for the third quarter of 2024
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Report for the Third Quarter of 2024
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024
Fangsheng Pharmaceutical: Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical
Fangsheng Pharmaceutical Report for the Third Quarter of 2024
Announcement of Resolutions of the 14th Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical
Fangsheng Pharmaceutical\'s business data announcement for the first three quarters of 2024
Fangsheng Pharmaceutical: Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Directors of Fangsheng Pharmaceutical in 2024
Fangsheng Pharmaceutical: Articles of Association of Fangsheng Pharmaceutical Company (to be submitted to the company\'s shareholders\' meeting for consideration)
Fangsheng Pharmaceutical: Announcement of Resolutions of the Eighth Interim Meeting of the 5th Fangsheng Pharmaceutical Supervisory Board in 2024
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s Announcement on the Transfer of Drug Ownership
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical\'s announcement on amending the “Articles of Association”
Fangsheng Pharmaceutical: Fangsheng Pharmaceutical Securities Investment Management System (reviewed and approved by the 8th Interim Meeting of the 5th Board of Directors in 2024)
Announcement of Resolutions of the Eighth Interim Meeting of the Fifth Board of Supervisors of Fangsheng Pharmaceutical in 2024
Fangsheng Pharmaceutical\'s announcement on the transfer of drug ownership
Articles of Association of Fangsheng Pharmaceutical Company (to be submitted to the company\'s shareholders\' meeting for consideration)
Fangsheng Pharmaceutical Securities Investment Management System (reviewed and approved by the 5th Board of Directors at the 8th Interim Meeting in 2024)
Fangsheng Pharmaceutical\'s announcement on amending the “Articles of Association”
Analysis
Price Target
No Data
No Data